{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:29:13Z","timestamp":1774578553739,"version":"3.50.1"},"reference-count":16,"publisher":"BMJ","issue":"8","funder":[{"name":"Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["21K07356"],"award-info":[{"award-number":["21K07356"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,8,9]]},"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>We report a case of cardiac amyloid A (AA) amyloidosis due to unicentric Castleman disease (UCD) in a patient whose cardiac function was restored 15 years after surgical resection of the mesenteric lymph node lesion. A man in his 40s had recurrent palpitations and fainting spells. ECG revealed <jats:italic>torsades de pointes<\/jats:italic>. Increased C-reactive protein, interleukin-6 and serum AA levels, and marked concentric thickening of the left ventricular (LV) wall with diastolic restrictive filling pattern were observed. Duodenal biopsy revealed AA amyloid deposits. He had a mesenteric tumour, comprising many plasma cells. He was diagnosed with plasma cell-type UCD associated with secondary AA amyloidosis. C-reactive protein, interleukin-6 and serum AA levels were normalised 2 months postresection. Episodes of lethal ventricular arrhythmias decreased. LV wall thickness was gradually reduced. Approximately 15 years postresection, the LV wall thickness nearly normalised and ventricular arrhythmias disappeared. Better outcomes are expected following surgical tumour resection.<\/jats:p>","DOI":"10.1136\/bcr-2022-250338","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:40:31Z","timestamp":1660822831000},"page":"e250338","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease"],"prefix":"10.1136","volume":"15","author":[{"given":"Kanako","family":"Imamura","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-7252","authenticated-orcid":false,"given":"Sunao","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sakura-jyuji Yatsushiro Rehabilitation Hospital, Yatsushiro, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Life Science, Shokei University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"2025082710384260000_15.8.e250338.1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.23907\/2016.054","article-title":"Amyloidosis and unexpected death: a review of seven cases","volume":"6","author":"Presnell","year":"2016","journal-title":"Acad Forensic Pathol"},{"key":"2025082710384260000_15.8.e250338.2","first-page":"178","article-title":"Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management","volume":"32","author":"Hassan","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"2025082710384260000_15.8.e250338.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016567"},{"key":"2025082710384260000_15.8.e250338.4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","article-title":"Cardiac amyloidosis: the need for early diagnosis","volume":"27","author":"Oerlemans","year":"2019","journal-title":"Neth Heart J"},{"key":"2025082710384260000_15.8.e250338.5","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2169\/internalmedicine.1099-18","article-title":"First nationwide survey of 199 patients with amyloid A amyloidosis in Japan","volume":"57","author":"Okuda","year":"2018","journal-title":"Intern Med"},{"key":"2025082710384260000_15.8.e250338.6","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318249dcdc"},{"key":"2025082710384260000_15.8.e250338.7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5603\/ARM.2018.0008","article-title":"The role of surgical resection in Unicentric Castleman's disease: a systematic review","volume":"86","author":"Mitsos","year":"2018","journal-title":"Adv Respir Med"},{"key":"2025082710384260000_15.8.e250338.8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13730-020-00511-8","article-title":"Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab","volume":"10","author":"Furutera","year":"2021","journal-title":"CEN Case Rep"},{"key":"2025082710384260000_15.8.e250338.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)89403-9"},{"key":"2025082710384260000_15.8.e250338.10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018978","article-title":"Aa amyloidosis associated with Castle man disease, a case report and review of the literature","volume":"99","author":"Bernabei","year":"2020","journal-title":"Medicine"},{"key":"2025082710384260000_15.8.e250338.11","first-page":"542","article-title":"Amyloid goiter with hypothyroidism","volume":"113","author":"Kanoh","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"2025082710384260000_15.8.e250338.12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1590\/1806-9282.66.3.345","article-title":"Cardiac amyloidosis: non-invasive diagnosis","volume":"66","author":"Hotta","year":"2020","journal-title":"Rev Assoc Med Bras"},{"key":"2025082710384260000_15.8.e250338.13","doi-asserted-by":"crossref","DOI":"10.1159\/000188652","article-title":"Torsade de pointes and sudden death in a patient with amyloidosis-associated nephropathy","volume":"70","author":"Yang","year":"1995","journal-title":"Nephron"},{"key":"2025082710384260000_15.8.e250338.14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/13506129.2011.636460","article-title":"Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis","volume":"19","author":"Hattori","year":"2012","journal-title":"Amyloid"},{"key":"2025082710384260000_15.8.e250338.15","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa449"},{"key":"2025082710384260000_15.8.e250338.16","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","article-title":"JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis","volume":"84","author":"Kitaoka","year":"2020","journal-title":"Circ J"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-250338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:38:48Z","timestamp":1756316328000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-250338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,18]]},"published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1136\/bcr-2022-250338"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-250338","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}